Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease.

BACKGROUND: Oxidative balance score (OBS) is a composite measure of oxidative stress-related exposures. The aim of this study was to investigate the association between OBS, end-stage renal disease (ESRD), and cardiovascular disease (CVD). METHODS: Using data from the Chronic Renal Insufficiency Cohort, we calculated the main exposure OBS by summing up 12 apriori-defined pro- and antioxidant factors obtained from the diet history questionnaire and lifestyle assessment. We divided OBS into quartiles (Q1-Q4), with Q1 (predominance of pro-oxidants) as the reference. We analyzed OBS quartiles as an ordinal variable. Crude and adjusted hazards ratios (HRs) and 95% CIs were estimated using Cox proportional hazards models for time to ESRD and CVD. RESULTS: Compared to Q1, Q4 (high antioxidant) was associated with ESRD in the crude model (HR 1.35, 95% CI 1.08-1.69) and adjusting for age, sex, and race (HR 1.36, 95% CI 1.09-1.71) but not in the fully adjusted model (HR 1.12, 95% CI 0.84-1.51). HR of ESRD increased as the OBS quartiles increased in the crude model (ptrend < 0.05) but not in the fully adjusted model (ptrend = 0.30). Compared to Q1, Q4 was associated with CVD in the crude (HR 1.33, 95% CI 1.06-1.68) but not adjusted models. The HR of CVD increased with an increase in OBS quartiles in the crude model (ptrend < 0.05). CONCLUSION: The reverse association between OBS and progression to ESRD suggests that perhaps the effect of oxidative balance-related exposure is different in the setting of established chronic kidney disease.

Tetrabromobisphenol A and hexabromocyclododecane isomers in breast milk from the general population in Beijing, China: Contamination levels, temporal trends, nursing infant's daily intake, and risk assessment.

Two currently used brominated flame retardants (BFRs), α, ß, γ-hexabromocyclododecane (HBCDD) and tetrabromobisphenol A (TBBPA), were measured in 111 breast milk samples from 37 Beijing mothers. Each mother provided one milk sample per month for 3 months. HBCDD was detected in almost all samples, and the median level reached 5.67 ng g-1 lipid weight (lw). α- HBCDD was the most abundant isomer (median: 4.23 ng g-1 lw), followed by γ- and ß-HBCDD. For TBBPA, a relatively lower detecting frequency (64%) and contamination level (median: 1.57 ng g-1 lw) were obtained. A comparison to our previous study revealed that the occurrence of TBBPA and HBCDD in Beijing human milk significantly rose from 2011 to 2014, whereas another commonly used class of BFRs, polybrominated diphenyl ethers (PBDEs), showed significantly decreased during this period. However, a comparison among currently used BFRs showed that levels of some BFRs, such as HBCDD, surpassed those of PBDEs, which indicated that PBDEs were no longer the primarily used BFR in China. However, no significant temporal trends for BFR levels were observed over the 3 months of lactation. Daily intakes of TBBPA and HBCDD were calculated for nursing infants and the median TBBPA and HBCDD intakes via breastfeeding were 6.62 and 26.4 ng kg-1 bw day-1, respectively. These values were several times higher than those for adults via food consumption. However, risk assessment using the margin of exposure approach indicated that intakes of TBBPA and HBCDD via breastfeeding can scarcely cause significant health risks to infants.

Polybrominated diphenyl ethers and novel brominated flame retardants in human milk from the general population in Beijing, China: Occurrence, temporal trends, nursing infants' exposure and risk assessment.

The levels of eight polybrominated diphenyl ether (PBDE) congeners, and six novel brominated flame retardants (NBFRs) were determined in human milk collected from Beijing, China in 2014. The tested 111 samples were collected from 37 mothers, and each donor provided one milk sample per month for 3 months after childbirth. Levels of ∑PBDEs (total tri- to deca-BDEs) were in the range of 0.288 to 22.2 ng g-1 lw (lipid weight). BDE-209, with a median level of 2.2 ng g-1 lw, was the predominant congener. Decabromodiphenyl ethane (DBDPE), as an NBFR and a substitute for deca-BDE, was found to be the most abundant BFR in all tested human milk (median:5.96 ng g-1 lw). This result might suggest that the predominantly consumed BFRs in China have changed from PBDEs to PBDE substitutes. Additionally, a comparison to our previous studies conducted in 2005 and 2011 revealed that levels of tri- to hepta-BDEs showed significant reduction from 2005 to 2014, whereas levels of BDE-209 showed no significant variation from 2011 to 2014. Temporal trends of BFR levels over the three months of lactation were also investigated, and no significant changes were found in concentration with time over the three months lactation. For nursing infants up to 6 months old, the median lower bound of daily BFR intakes via human milk ingestion ranged from zero for 2,3-dibromopropyl-2,4,6-tribromophenyl ether (DPTE) and 1,2-bis(2,4,6-tribromophenoxy)-ethane (BTBPE) to 18.7 ng kg-1 bodyweight day-1 for DBDPE. Although the daily dietary BFR intake for nursing infants was found to be much higher than that for adults, the risk assessment evaluated by the margin of exposure (MOE) approach revealed that dietary BFR intake for nursing infants was unlikely to pose significant health risks.